Deutsche Bank Analyst Says AstraZeneca’s Outlook for Next Year Is Complex

Deutsche Bank’s Emmanuel Papadakis said in a research note that AstraZeneca’s outlook for next year seems complex. The drugmaker reported mixed third-quarter results, and its shares have recently benefited from broad-based sector strength.